The first Middle East and North Africa expert consensus recommendations for management of advanced gastric cancer.


Journal

Future oncology (London, England)
ISSN: 1744-8301
Titre abrégé: Future Oncol
Pays: England
ID NLM: 101256629

Informations de publication

Date de publication:
Jul 2023
Historique:
medline: 16 8 2023
pubmed: 1 8 2023
entrez: 1 8 2023
Statut: ppublish

Résumé

Gastric cancer (GC) ranks as the fifth most prevalent cancer and the fourth deadliest cancer worldwide. In the Middle East and North Africa (MENA) region, GC represents about 4.8% of cancer cases with more than 35,000 new cases in 2020. To strengthen and improve the management of this cancer in the region, a group of MENA experts in the field of GC developed the first MENA consensus recommendations for the management of advanced GC. A total of 28 statements were drafted, discussed and voted on, using a modified Delphi process, during a virtual consensus meeting. The statements addressed the areas of epidemiology, biomarkers and treatment.

Identifiants

pubmed: 37526151
doi: 10.2217/fon-2023-0219
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1451-1459

Auteurs

Hampig Raphael Kourie (HR)

Hematology-Oncology Department, Saint Joseph University of Beirut, Lebanon.

Mervat Mahrous (M)

Prince Sultan Military Medical City, Riyadh, KSA.
Oncology Department, Minia University, Minia, Egypt.

Nabih Naim (N)

Hematology-Oncology Department, Saint Joseph University of Beirut, Lebanon.

Joseph Zouein (J)

Hematology-Oncology Department, Saint Joseph University of Beirut, Lebanon.

Zineb Benbrahim (Z)

CHU Hassan II, Morocco.

Kakil Rasul (K)

Natonal Center for Cancer Care & Research in Hamad Medical Corporation, Doha, Qatar.

Mohsen Mokhtar (M)

Director of Kasr Al Aini Oncology Unit, Cairo University, Egypt.

Ahmad Al Shehri (AA)

King Abdullah Medical City, Jeddah, KSA.

Mahmoud Shakeeb (M)

Medical City Complex, Baghdad, Iraq.

Sami Khatib (S)

Secretary General of the Arab Medical Association Against Cancer, Jordan.

Humaid Al-Shamsi (H)

President of the Emirates Oncology Society, Burjeel Cancer Institute & VPS Healthcare, UAE.

Ali Shamseddine (A)

Director of Gastrointestinal/Genitourinary Cancer Program at the Hematology-Oncology Division Basile Cancer Institute, American University of Beirut, Lebanon.

Elisabeth Smyth (E)

Cambridge University Hospital, NHS Foundation Trust, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH